+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Self-administered Injectable Drug Therapies and Markets

  • PDF Icon

    Report

  • 234 Pages
  • September 2023
  • Region: Global
  • Greystone Associates
  • ID: 5897259

For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade - tools that include 3D CAD design software and high-performance materials, design team have been increasingly relying on classic end user research to define the design targets for their projects.

For specialty prefilled injection devices - a group that includes prefilled pen injectors, autoinjectors and needle-free injection devices - the ability to create product differentiation in the age of direct-to-consumer marketing and competition from generics provide incentives to consider this higher-cost option. Specialty device features such as multi-dose drug cartridges and integrated dose counters can improve ease-of-use for self-administration and create brand loyalty among consumers with chronic conditions.

What You Will Learn

  • Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.
  • Assesses key markets, market dynamics and market demographics.
  • Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.
  • Provides market data and forecasts.
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on drug product commercialization.
  • Evaluates the impact of economic, technology, and regulatory factors

Table of Contents


1. Executive Summary2. The Market Opportunity
3. Delivery Market Dynamics
  • The Economics of Injectable Drugs
  • What’s Driving the Growth in Injectable Devices?
  • Prefilled Syringes Proliferating
  • The Prefilled Syringe Supply Chain
  • The Trend toward Self- Administration
  • Shifting Demographics
  • Innovation in Disposable Device Designs
  • Proliferation of Biological Drugs
4. Therapeutic Monoclonal Antibodies
5. Injectable Drug Device Summaries
  • Autoinjectors
  • Single Fixed Dose
  • Variable Dosing
  • High Viscosity
  • Dual Chamber
6. Wirelessly Enabled Autoinjectors
  • Selected Product Specific Autoinjectors
7. Autoinjector Device Design Factors
  • Material Selection Issues
  • Part Counts and Device Cost
  • Safety Features
  • Needle Insertion Depth
  • Failsafe Activation
  • Dose Inspection/Injection Confirmation
  • Market Factors
  • Lyophilized Drugs/Reconstitution
  • Human Engineering/Ergonomics
8. Pen Injectors
  • Pen Injector Design Selection Factors
  • Standardized Pen Platforms
  • Custom Pen Designs
  • Reusable Pens
  • Dual Chamber Pens
9. Commercial Pen Products
  • Hormones
  • Enzymes
  • Insulins
  • Detailed Profiles of 23 Devices
10. Wearable Devices - Analysis and Assessments
  • Libertas (Becton Dickinson)
  • SmartDose (West Pharmaceuticals)
  • Neulasta OnPro Injector (Insulet/Amgen)
  • YpsoDose (Ypsomed)
  • Electronic Semi-disposable
  • eLVD Patch Pump (Elcam)
11. Emerging Technology
  • Wireless Data
12. Injectable Drug Market Analysis and Forecasts
  • Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis
  • Hematopoietics
  • Hormones
  • Osteoporosis
  • Fertility
13. Market Factors
  • Regulatory Issues
  • Device Branding
  • Patient Adherence and Ease of Use
  • Healthcare Economics
14. Company Profiles

Companies Mentioned

  • Becton Dickinson
  • West Pharmaceuticals
  • Insulet/Amgen
  • Ypsomed
  • Elcam